(Q44425255)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22659680%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

title

Allo-SCT for high-risk AML-CR1 in the molecular era: impact of FLT3/ITD outweighs the conventional markers (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22659680%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

author

Stephen A. Strickland

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22659680%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

author name string

S M Sengsayadeth

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22659680%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

M Jagasia

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22659680%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

B G Engelhardt

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22659680%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

A Kassim

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22659680%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

S Goodman

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22659680%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

C Lucid

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22659680%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

C L Vnencak-Jones

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22659680%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

J P Greer

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22659680%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

B N Savani

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22659680%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

language of work or name

English

0 references

publication date

4 June 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22659680%20AND%20SRC:MED&resulttype=core&format=json

Bone Marrow Transplantation

3 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22659680%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

volume

47

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22659680%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22659680%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

page(s)

1535-1537

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22659680%20AND%20SRC:MED&resulttype=core&format=json

Analysis of FLT3-activating mutations in 979 patients with acute myelogenous leukemia: association with FAB subtypes and identification of subgroups with poor prognosis

3 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.88

Prognostic significance of activating FLT3 mutations in younger adults (16 to 60 years) with acute myeloid leukemia and normal cytogenetics: a study of the AML Study Group Ulm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.88

Prognostic significance of FLT3 internal tandem duplication and tyrosine kinase domain mutations for acute myeloid leukemia: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.88

Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.88

Role of allogeneic transplantation for FLT3/ITD acute myeloid leukemia: outcomes from 133 consecutive newly diagnosed patients from a single institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.88

FLT3 mutations in normal karyotype acute myeloid leukemia in first complete remission treated with autologous peripheral blood stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.88

Interactive diagnostics in the indication to allogeneic SCT in AML.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.88

Management of relapse after allo-SCT for AML and the role of second transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.88

NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on the Epidemiology and Natural History of Relapse following Allogeneic Cell Tr

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.88

FLT3/ITD AML and the law of unintended consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.88

Myeloablative reduced-toxicity i.v. busulfan-fludarabine and allogeneic hematopoietic stem cell transplant for patients with acute myeloid leukemia or myelodysplastic syndrome in the sixth through eighth decades of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.88

Toxic effects of sorafenib when given early after allogeneic hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.88

Molecular remission of FLT3-ITD(+) positive AML relapse after allo-SCT by acute GVHD in addition to sorafenib.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.88

Posttransplantation vaccination: concepts today and on the horizon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.88

Transplantation in AML CR1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.88

7 January 2021

Improved outcome after stem-cell transplantation in FLT3/ITD-positive AML

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.88

7 January 2021

Role of allogeneic stem cell transplantation in FLT3/ITD-positive AML

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.88

7 January 2021

Donor erythrocytosis induced by sorafenib treatment after allogeneic hematopoietic SCT in a patient with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2012.88

7 January 2021

Identifiers

DOI

10.1038/BMT.2012.88

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22659680%20AND%20SRC:MED&resulttype=core&format=json

release_jf5qqajvy5gmti5sto2p5p2gbm

3 February 2020

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/jf5qqajvy5gmti5sto2p5p2gbm

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22659680%20AND%20SRC:MED&resulttype=core&format=json